CLINICAL_TRIALS
trial_result
· 2007-07-31
Clinical Trial Update: Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery [Phase 3]
Summary
A Phase 3 clinical trial evaluating rivastigmine to prevent postoperative delirium in patients undergoing cardiac surgery has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Basel, Switzerland | Conditions: Delirium | Phase 3 | Status: COMPLETED